Modulation of hepatic PPAR expression during Ft LVS LPS-induced protection from Francisella tularensis LVS infection

BMC Infect Dis. 2010 Jan 18:10:10. doi: 10.1186/1471-2334-10-10.

Abstract

Background: It has been shown previously that administration of Francisella tularensis (Ft) Live Vaccine Strain (LVS) lipopolysaccharide (LPS) protects mice against subsequent challenge with Ft LVS and blunts the pro-inflammatory cytokine response.

Methods: To further investigate the molecular mechanisms that underlie Ft LVS LPS-mediated protection, we profiled global hepatic gene expression following Ft LVS LPS or saline pre-treatment and subsequent Ft LVS challenge using Affymetrix arrays.

Results: A large number of genes (> 3,000) were differentially expressed at 48 hours post-infection. The degree of modulation of inflammatory genes by infection was clearly attenuated by pre-treatment with Ft LVS LPS in the surviving mice. However, Ft LVS LPS alone had a subtle effect on the gene expression profile of the uninfected mice. By employing gene set enrichment analysis, we discovered significant up-regulation of the fatty acid metabolism pathway, which is regulated by peroxisome proliferator activated receptors (PPARs).

Conclusions: We hypothesize that the LPS-induced blunting of pro-inflammatory response in mouse is, in part, mediated by PPARs (alpha and gamma).

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bacterial Vaccines / immunology*
  • Fatty Acids / metabolism
  • Female
  • Francisella tularensis
  • Gene Expression Profiling
  • Lipopolysaccharides / administration & dosage
  • Liver / metabolism*
  • Mice
  • Mice, Inbred C57BL
  • Oligonucleotide Array Sequence Analysis
  • Peroxisome Proliferator-Activated Receptors / metabolism*
  • Tularemia / genetics*
  • Tularemia / immunology
  • Vaccines, Attenuated / immunology

Substances

  • Bacterial Vaccines
  • Fatty Acids
  • Lipopolysaccharides
  • Peroxisome Proliferator-Activated Receptors
  • Vaccines, Attenuated